Oncology News Central (ONC)“A Real Insult”: Oncologists Outraged Over Downcoding Policy

Cigna’s new national E/M downcoding policy (effective October 1, 2025) automatically adjusts Level 4 and 5 evaluation and management codes without reviewing medical records, targeting providers with “consistent patterns” of higher-level coding compared to peers. The automated system uses claim data and diagnoses only, requiring physicians to appeal downcodes via hard copy or fax. Similar policies from Aetna, Anthem, and other insurers represent an industry-wide trend toward algorithm-based claim adjustments that lack transparency in criteria, selection processes, and timeframes.

⚖️ Professional Impact Points

• Automated downcoding without medical record review undermines clinical autonomy and dismisses physician judgment regarding patient complexity, particularly problematic in oncology where cancer patients frequently present with high-acuity conditions, treatment side effects, comorbidities, and multiple malignancies requiring intensive management.
• Professional liability concerns emerge when insurers dictate coding levels that may not reflect documented medical necessity, creating potential conflicts between appropriate billing for services rendered and payer-imposed adjustments that could affect standard-of-care documentation and future audit defense.
• Lack of transparency in selection criteria and algorithm parameters prevents physicians from understanding how they’re flagged for review or what constitutes “consistent patterns,” making it impossible to proactively adjust documentation practices or defend against arbitrary downcoding decisions.
• Oncology’s high-complexity patient population may increase targeting risk despite Cigna FAQ suggestions that “claims for cancer” won’t be adjusted—a protection not included in official policy documents and therefore unenforceable, leaving oncologists vulnerable to disproportionate review.
• Industry-wide adoption establishes concerning precedent where payers unilaterally reduce reimbursement through undisclosed algorithms, shift burden of proof to providers through cumbersome appeal processes, and can arbitrarily expand affected provider percentages (currently 3%) without notice or justification.

🏥 Practice Management Considerations

• Documentation Strategy: Meticulously document all medical decision-making elements (problem complexity, data reviewed, risk level) or time spent for Level 4 and 5 E/M codes using AMA guidelines; maintain detailed records showing patient acuity, comorbidities, and treatment complexity to support appeals and protect against liability exposure.
• Revenue Cycle Monitoring: Implement vigilant claim tracking systems to identify downcodes immediately, as payers increasingly adjust payments without changing billed codes, making detection difficult; small practices face cash flow crises when payments are delayed or reduced without notice, with appeal deadlines potentially expiring before downcodes are discovered.
• Appeal Process Infrastructure: Develop immediate-response protocols with template appeal letters, designated staff for downcode identification, and systems for pulling supporting documentation quickly; prepare for resource-intensive appeals requiring hard copy or fax submission, increasing administrative costs while simultaneously reducing revenue.
• Payer Relations Development: Establish or strengthen communication channels with insurers to extract available information about review processes, selection criteria, and navigation strategies; leverage relationships to advocate for transparency and fair treatment while gathering intelligence on policy application.
• Legal Risk Mitigation: Monitor for patterns of systematic downcoding that could support legal challenges; document all downcodes, appeals, and outcomes; stay informed about regulatory challenges like California’s Department of Managed Health Care review and potential federal legislative responses to industry-wide practices.

HCN Medical Memo
Immediately audit E/M documentation to ensure compliance with AMA Level 4 and 5 requirements while implementing real-time claim monitoring to detect downcodes. Engage with specialty societies, state medical associations, and advocacy groups pursuing regulatory review of these policies—California Medical Association’s success in pausing Cigna’s policy demonstrates potential for collective action. Prepare for increased administrative burden by reallocating resources to appeal management while documenting financial impact for potential legal or regulatory challenges.

More on Coding & Reimbursement